April 2022

CNS Drugs Take 20% Longer to Develop and to Approve vs. Non-CNS Drugs

Central Nervous System Therapeutics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Report Linker (April 22, 2022). Access article

Over 10,000 Diseases And Only 50 Drugs Approved In 2021. To Improve Pharma R&D Efficiency We Need To Understand It.

Over 10,000 Diseases And Only 50 Drugs Approved In 2021. To Improve Pharma R&D Efficiency We Need To Understand It.

Forbes (April 11, 2022). Access article

The Incidence of Protocol Deviations and Amendments is High and Rising

Why clinical trials need expert support for ongoing success

Clinical Trials Arena (April 6, 2022). Access article


March 2022

Tufts CSDD Study on Staff Diversity in Global Investigative Sites

Restoring trust in clinical trials among Black communities

MedCity News (March 18, 2022). Access article

Measuring Patient Satisfaction as a Primary Outcome for Patient-Centric Initiatives

Measuring Patient Satisfaction as a Primary Outcome for Patient-Centric Initiatives

Applied Clinical Trials (March 17, 2022). Access article

Rising Protocol Design Complexity Is Driving Rapid Growth in Clinical Trial Data Volume

eClinical Solutions Drives Strong Annual Growth Marked by New Products, Employee Hirings, and Expansion in West Coast and European Life Science Markets

Business Wire (March 10, 2022). Access article


February 2022

Assessing the Impact of DCT on Outsourced Relationships

Characterizing the Process of Adopting Innovations Supporting Drug Development Operations

Applied Clinical Trials (February 7, 2022). Access article


January 2022

Protocol Complexity and Patient Enrollment Intensify Challenges in Oncology Trials

No End in Sight for Trial Complexity, CSDD Report Reveals

CenterWatch (January 17, 2022). Access article

Assessing the Impact of DCT on Outsourced Relationships

Tufts links decentralized clinical trials to shorter cycle times, cost savings

Outsourcing Pharma (January 28, 2022). Access article 

 

Decentralized clinical trials can achieve net financial benefits 5 to 14 times

The Health Guild (January 13, 2022). Access article

 

New Study: Decentralized Clinical Trials Can Achieve Net Financial Benefits of 5X to 14X, Due to Reduced Trial Timelines and Other Factors

Business Wire (January 13, 2022). Access article

 

Not just for a pandemic: Decentralized clinical trials pay off financially, study finds

Fierce Biotech (January 12, 2022). Access article

 

Latest financial model shows substantial net benefits for sponsors that use DCTs

Medable (January 12, 2022). Download White Paper

The Incidence of Protocol Deviations and Amendments in Trials is High and Rising 

Trial by fire: More study protocols are experiencing substantial — and costly — changes

StatNews (January 10, 2022). Access article


December 2021

New Study Finds Site Personnel Race and Ethnicity Highly Correlated with Diversity of Patients Enrollment - Press Release

To Increase Diversity in Clinical Trials, First Increase Staff Diversity

TuftsNow (December 3, 2021). Access article


November 2021

New Study Finds Site Personnel Race and Ethnicity Highly Correlated with Diversity of Patients Enrollment - Press Release

Dedicated Sites, Private Practices Outdoing AMCs on Diversity Front                   

CenterWatch (November 15, 2021). Access article

 

Clinical trial sites face challenges in diversifying personnel and participants, study finds                  

StatNews (November 5, 2021). Access article

Race, ethnicity of trial patients 'highly correlated' with staff of site investigators: study

FierceBiotech (November 3, 2021). Access article

Diversity of Site Staff Highly Associated with Diversity of Patients Enrolled Trials, According to Tufts

Applied Clinical Trials (November 2, 2021). Access article